PUBLIC COMPANY
save$EXELEXELIXIS, INC.
$EXEL51.24+1.24%Alameda, CA, USupdated 14h ago
Exelixis, Inc. is a genomics-based drug discovery company located in Alameda, California, and the producer of Cometriq, a treatment approved by the U.S. Food and Drug Administration (FDA) for medullary thyroid cancer with clinical activity in several other types of metastatic cancer.
community read0 votes
pipeline
8
marketed
1
phase 3
1
catalysts ytd
2
approvals ytd
0
recalls ytd
0
Pipeline(8)
pipeline depth8 products
4Phase 11Phase 31Marketed1pre_registration1Unknown
Marketed
cabozantinib s-malate
Endometrial Cancer
Hepatocyte growth factor receptorVascular endothelial growth factor receptor 2
Phase 3CABOMETYX
1 INDICATIONS AND USAGE CABOMETYX is a kinase inhibitor i…
Hepatocyte growth factor receptorVascular endothelial growth factor receptor 2
Phase 1XB-010
Endometrial Cancer
Phase 1XB-371
Solid Tumor
Phase 1XB-628
Solid Tumor
Phase 1XL-309
Fallopian Tube Cancer
drugCOMETRIQ
1 INDICATIONS AND USAGE COMETRIQ is indicated for the tre…
Hepatocyte growth factor receptorVascular endothelial growth factor receptor 2
pre_registrationzanzalintinib fumarate
Metastatic Colorectal Cancer
Upcoming
Recent(90d)
nothing in the last 90 days
view all catalysts →Insider activity
source: SEC Form 4open-market buys + sells
- Feb 24, 26SELLAftab Dana· EVP, Research and Development−$2.13M↗
- Feb 19, 26SELLAftab Dana· EVP, Research and Development−$1.32M↗
- Feb 18, 26SELLWYSZOMIERSKI JACK L· director−$4.38M↗
- Feb 18, 26SELLSmith Julie· director−$1.96M↗
- Feb 18, 26SELLSmith Julie· director−$887K↗
- Feb 18, 26SELLHefti Brenda· SVP and General Counsel−$822K↗
- Feb 17, 26SELLHaley Patrick J.· EVP, Commercial−$2.82M↗
- Feb 17, 26SELLSmith Julie· director−$1.84M↗
- Feb 17, 26SELLSenner Christopher J.· EVP and CFO−$1.34M↗
- Feb 17, 26SELLHaley Patrick J.· EVP, Commercial−$133K↗
routine RSU / option mechanics (6)
- Feb 26, 26grantAftab Dana · EVP, Research and Development52,018 sh
- Feb 26, 26grantSenner Christopher J. · EVP and CFO52,018 sh
- Feb 26, 26grantHefti Brenda · SVP and General Counsel23,119 sh
- Feb 26, 26grantHaley Patrick J. · EVP, Commercial40,459 sh
- Feb 26, 26grantMORRISSEY MICHAEL · President and CEO160,437 sh
- Feb 24, 26giftMORRISSEY MICHAEL · President and CEO100,278 sh
🐶 Hiring Signal
next earnings Oct 27, 2026
News
no news has mentioned this company yet
Data sources
last refreshed 16m ago
Found something off?
comments(0)
5-min edit window · permanent after that